By Professor Susan Ramus

Journal articles

Ramachandran D; Tyrer JP; Kommoss S; DeFazio A; Riggan MJ; Webb PM; Fasching PA; Lambrechts D; García MJ; Rodríguez-Antona C; Goodman MT; Modugno F; Moysich KB; Karlan BY; Lester J; Kjaer SK; Jensen A; Høgdall E; Goode EL; Cliby WA; Kumar A; Wang C; Cunningham JM; Winham SJ; Monteiro AN; Schildkraut JM; Cramer DW; Terry KL; Titus L; Bjorge L; Thomsen LCV; Pejovic T; Høgdall CK; McNeish IA; May T; Huntsman DG; Pfisterer J; Canzler U; Park-Simon TW; Schröder W; Belau A; Hanker L; Harter P; Sehouli J; Kimmig R; de Gregorio N; Schmalfeldt B; Baumann K; Hilpert F; Burges A; Winterhoff B; Schürmann P; Speith LM; Hillemanns P; Berchuck A; Johnatty SE; Ramus SJ; Chenevix-Trench G; Pharoah PDP; Dörk T; Heitz F; Bowtell D; Fereday S; Traficante N; Hung J; Friedlander M; Obermair A; Grant P; Beesley V; Blomfield P; Brand A; Davis A; Leung Y; Nicklin J; Quinn M; Livingstone K; O’Neill H; Williams M, 2024, 'Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease', npj Genomic Medicine, 9, http://dx.doi.org/10.1038/s41525-024-00395-y

Nelson BH; Hamilton PT; Phung MT; Milne K; Harris B; Thornton S; Stevens DL; Kalaria S; Singh K; Laumont CM; Moss E; Alimujiang A; Meagher NS; Bolithon A; Fereday S; Kennedy CJ; Hendley J; Ariyaratne D; Alsop K; Traficante N; Goode EL; Karnezis AN; Shen H; Richardson J; McKinnon Deurloo C; Chase A; Grout B; Doherty JA; Harris HR; Cushing-Haugen KL; Anglesio MS; Heinze K; Huntsman D; Talhouk A; Hanley GE; Alsop J; Jimenez-Linan M; Pharoah PD; Boros J; Brand AH; Harnett PR; Sharma R; Hecht JL; Sasamoto N; Terry KL; Karlan BY; Lester J; Carney ME; Goodman MT; Hernandez BY; Wilkens LR; Behrens S; Turzanski Fortner R; Fasching PA; Bisinotto C; Candido Dos Reis FJ; Ghatage P; Köbel M; Elishaev E; Modugno F; Cook LS; Le ND; Gentry-Maharaj A; Menon U; García MJ; Rodriguez-Antona C; Farrington KM; Kelemen LE; Kommoss S; Staebler A; Garsed DW; Brenton JD; Piskorz AM; Bowtell DD; DeFazio A; Ramus SJ; Pike MC; Pearce CL, 2024, 'Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.', J Clin Invest, 134, http://dx.doi.org/10.1172/JCI179501

Davidson AL; Michailidou K; Parsons MT; Fortuno C; Bolla MK; Wang Q; Dennis J; Naven M; Abubakar M; Ahearn TU; Alonso MR; Andrulis IL; Antoniou AC; Auvinen P; Behrens S; Bermisheva MA; Bogdanova NV; Bojesen SE; Brüning T; Byers HJ; Camp NJ; Campbell A; Castelao JE; Cessna MH; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Sahlberg KK; Børresen-Dale AL; Gram IT; Olsen KS; Engebråten O; Naume B; Geisler J; OSBREAC ; Grenaker Alnæs GI; Collée JM; Czene K; Dörk T; Eriksson M; Evans DG; Fasching PA; Figueroa JD; Flyger H; Gago-Dominguez M; García-Closas M; Glendon G; González-Neira A; Grassmann F; Gronwald J; Guénel P; Hadjisavvas A; Haeberle L; Hall P; Hamann U; Hartman M; Ho PJ; Hooning MJ; Hoppe R; Howell A; Amor D; Andrews L; Antill Y; Balleine R; Beesley J; Bennett I; Bogwitz M; Bodek S; Botes L; Brennan M; Brown M; Buckley M; Burke J; Butow P; Caldon L; Campbell I; Cao M; Chakrabarti A; Chauhan D; Chauhan M; Christian A; Cohen P; Colley A; Crook A; Cui J; Courtney E; Cummings M; Dawson SJ; deFazio A; Delatycki M; Dickson R; Dixon J; Edwards S; Farshid G; Fellows A; Fenton G; Field M; Flanagan J; Fong P; Forrest L, 2024, 'Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset', American Journal of Human Genetics, 111, pp. 2059 - 2069, http://dx.doi.org/10.1016/j.ajhg.2024.07.004

Saner FAM; Takahashi K; Budden T; Pandey A; Ariyaratne D; Zwimpfer TA; Meagher NS; Fereday S; Twomey L; Pishas KI; Hoang T; Bolithon A; Traficante N; Alsop K; Christie EL; Kang EY; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Alsop J; Beckmann MW; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; El-Bahrawy MA; Elishaev E; Erber R; Gayther SA; Gentry-Maharaj A; Blake Gilks C; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Jakubowska A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Kluz T; Koziak JM; Kristjansdottir B; Le ND; Lener M; Lester J; Lubiński J; Mateoiu C; Orsulic S; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Rinda Soong T; Steed H; Sukumvanich P; Talhouk A; Taylor SE; Vierkant RA; Wang C; Widschwendter M; Wilkens LR; Winham SJ; Anglesio MS; Berchuck A; Brenton JD; Campbell I; Cook LS; Doherty JA; Fasching PA; Fortner RT; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sundfeldt K; Swerdlow AJ; Goode EL; DeFazio A; Köbel M; Ramus SJ; Bowtell DDL; Garsed DW, 2024, 'Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma', Clinical Cancer Research, 30, pp. 3481 - 3498, http://dx.doi.org/10.1158/1078-0432.CCR-23-3552

Dareng EO; Coetzee SG; Tyrer JP; Peng PC; Rosenow W; Chen S; Davis BD; Dezem FS; Seo JH; Nameki R; Reyes AL; Aben KKH; Anton-Culver H; Antonenkova NN; Aravantinos G; Bandera EV; Beane Freeman LE; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bernardini MQ; Bjorge L; Black A; Bogdanova NV; Bolton KL; Brenton JD; Budzilowska A; Butzow R; Cai H; Campbell I; Cannioto R; Chang-Claude J; Chanock SJ; Chen K; Chenevix-Trench G; Chiew YE; Cook LS; DeFazio A; Dennis J; Doherty JA; Dörk T; du Bois A; Dürst M; Eccles DM; Ene G; Fasching PA; Flanagan JM; Fortner RT; Fostira F; Gentry-Maharaj A; Giles GG; Goodman MT; Gronwald J; Haiman CA; Håkansson N; Heitz F; Hildebrandt MAT; Høgdall E; Høgdall CK; Huang RY; Jensen A; Jones ME; Kang D; Karlan BY; Karnezis AN; Kelemen LE; Kennedy CJ; Khusnutdinova EK; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Labrie M; Lambrechts D; Larson MC; Le ND; Lester J; Li L; Lubiński J; Lush M; Marks JR; Matsuo K; May T; McLaughlin JR; McNeish IA; Menon U; Missmer S; Modugno F; Moffitt M; Monteiro AN; Moysich KB; Narod SA; Nguyen-Dumont T; Odunsi K; Olsson H; Onland-Moret NC; Park SK; Pejovic T; Permuth JB; Piskorz A; Prokofyeva D, 2024, 'Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions', American Journal of Human Genetics, 111, pp. 1061 - 1083, http://dx.doi.org/10.1016/j.ajhg.2024.04.011

Köbel M; Kang EY; Lee S; Terzic T; Karnezis AN; Ghatage P; Woo L; Lee CH; Meagher NS; Ramus SJ; Gorringe KL, 2024, 'Infiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma', Histopathology, 84, pp. 1095 - 1110, http://dx.doi.org/10.1111/his.15128

Zwimpfer TA; Pandey A; Fereday S; Coelho RJB-N; Twomey L; Ariyaratne D; Traficante N; Jacob F; Eller R; Heinzelmann-Schwarz V; Christie EL; Kennedy C; Au-Yeung G; Ramus S; Koebel M; Nelson B; Goode EL; DeFazio A; Bowtell DDL; Garsed DW, 2024, '752P Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival', Annals of Oncology, 35, pp. S571 - S571, http://dx.doi.org/10.1016/j.annonc.2024.08.813

Heinze K; Cairns ES; Thornton S; Harris B; Milne K; Grube M; Meyer C; Karnezis AN; Fereday S; Garsed DW; Leung SCY; Chiu DS; Moubarak M; Harter P; Heitz F; McAlpine JN; DeFazio A; Bowtell DDL; Goode EL; Pike M; Ramus SJ; Pearce CL; Staebler A; K€obel M; Kommoss S; Talhouk A; Nelson BH; Anglesio MS, 2023, 'The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas', Clinical Cancer Research, 29, pp. 3471 - 3483, http://dx.doi.org/10.1158/1078-0432.CCR-22-3815

Morra A; Schreurs MAC; Andrulis IL; Anton-Culver H; Augustinsson A; Beckmann MW; Behrens S; Bojesen SE; Bolla MK; Brauch H; Broeks A; Buys SS; Camp NJ; Castelao JE; Cessna MH; Chang-Claude J; Chung WK; Sahlberg KK; Børresen-Dale AL; Gram IT; Olsen KS; Engebråten O; Naume B; Geisler J; Grenaker Alnæs GI; Colonna SV; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Dennis J; Devilee P; Dörk T; Dunning AM; Dwek M; Easton DF; Eccles DM; Eriksson M; Evans DG; Fasching PA; Fehm TN; Figueroa JD; Flyger H; Gabrielson M; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Genkinger J; Grassmann F; Gündert M; Hahnen E; Haiman CA; Hamann U; Harrington PA; Hartikainen JM; Hoppe R; Hopper JL; Houlston RS; Howell A; Clarke C; Marsh D; Scott R; Baxter R; Yip D; Carpenter J; Davis A; Pathmanathan N; Simpson P; Graham JD; Sachchithananthan M; Amor D; Andrews L; Antill Y; Balleine R; Beesley J; Bennett I; Bogwitz M; Botes L; Brennan M; Brown M; Buckley M; Burke J; Butow P; Caldon L; Campbell I; Cao M; Chakrabarti A; Chauhan D; Chauhan M; Chenevix-Trench G; Christian A; Cohen P; Colley A; Crook A; Cui J; Courtney E; Cummings M; Dawson SJ; DeFazio A, 2023, 'Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival', Cancer Medicine, 12, pp. 16142 - 16162, http://dx.doi.org/10.1002/cam4.6272

O’Mahony DG; Ramus SJ; Southey MC; Meagher NS; Hadjisavvas A; John EM; Hamann U; Imyanitov EN; Andrulis IL; Sharma P; Daly MB; Hake CR; Weitzel JN; Jakubowska A; Godwin AK; Arason A; Bane A; Simard J; Soucy P; Caligo MA; Mai PL; Claes KBM; Teixeira MR; Chung WK; Lazaro C; Hulick PJ; Toland AE; Pedersen IS; Mourits MJE; Neuhausen SL; Vega A; de la Hoya M; Nevanlinna H; Dhawan M; Zampiga V; Danesi R; Varesco L; Gismondi V; Vellone VG; James PA; Janavicius R; Nikitina-Zake L; Nielsen FC; van Overeem Hansen T; Pejovic T; Borg A; Rantala J; Offit K; Montagna M; Nathanson KL; Domchek SM; Osorio A; García MJ; Karlan BY; Lesueur F; De Fazio A; Bowtell D; McGuffog L; Leslie G; Parsons MT; Dörk T; Speith LM; dos Santos ES; da Costa AABA; Radice P; Peterlongo P; Papi L; Engel C; Hahnen E; Schmutzler RK; Wappenschmidt B; Easton DF; Tischkowitz M; Singer CF; Tan YY; Whittemore AS; Sieh W; Brenton JD; Yannoukakos D; Fostira F; Konstantopoulou I; Soukupova J; Vocka M; Chenevix-Trench G; Pharoah PDP; Antoniou AC; Goldgar DE; Spurdle AB; Michailidou K, 2023, 'Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2', British Journal of Cancer, 128, pp. 2283 - 2294, http://dx.doi.org/10.1038/s41416-023-02263-5

Figlioli G; Billaud A; Ahearn TU; Antonenkova NN; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Blok MJ; Bogdanova NV; Bonanni B; Burwinkel B; Camp NJ; Campbell A; Castelao JE; Cessna MH; Chanock SJ; Alnæs GIG; Sørlie T; Skjerven HK; Russnes HG; Mælandsmo GM; Lingjærde OC; Langerød A; Hofvind S; Geitvik GA; Garred Ø; Fritzman B; Borgen E; Bathen TF; Geisler J; Naume B; Engebråten O; Olsen KS; Gram IT; Børresen-Dale AL; Sahlberg KK; Czene K; Devilee P; Dörk T; Engel C; Eriksson M; Fasching PA; Figueroa JD; Gabrielson M; Gago-Dominguez M; García-Closas M; González-Neira A; Grassmann F; Guénel P; Gündert M; Hadjisavvas A; Hahnen E; Hall P; Hamann U; Harrington PA; He W; Hillemanns P; Hollestelle A; Hooning MJ; Hoppe R; Howell A; Humphreys K; Zaheed M; Young MA; Winship I; Williams R; Walker L; Visvader J; Tucker K; Trainer A; Thorne H; Taylor R; Taylor J; Spurdle A; Southey M; Simpson P; Shelling A; Sexton A; Scott C; Scott R; Saunus J; Saunders C; Salisbury E; Skandarajah A; Saleh M; Robinson B; Rickard E; Ramus S; Pieper E; Phillips K; Pearn A; Patterson B; Pathak G; Pang JM; Pachter N; Ortega DG; O’Sullivan S; O’Connell S, 2023, 'FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women', European Journal of Human Genetics, 31, pp. 578 - 587, http://dx.doi.org/10.1038/s41431-022-01257-w

Fu Z; Brooks MM; Irvin S; Jordan S; Aben KKH; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Brooks-Wilson A; Chang-Claude J; Cook LS; Cramer DW; Cushing-Haugen KL; Doherty JA; Ekici AB; Fasching PA; Fortner RT; Gayther SA; Gentry-Maharaj A; Giles GG; Goode EL; Goodman MT; Harris HR; Hein A; Kaaks R; Kiemeney LA; Köbel M; Kotsopoulos J; Le ND; Lee AW; Matsuo K; Mcguire V; Mclaughlin JR; Menon U; Milne RL; Moysich KB; Pearce CL; Pike MC; Qin B; Ramus SJ; Riggan MJ; Rothstein JH; Schildkraut JM; Sieh W; Sutphen R; Terry KL; Thompson PJ; Titus L; Van Altena AM; White E; Whittemore AS; Wu AH; Zheng W; Ziogas A; Taylor SE; Tang L; Songer T; Wentzensen N; Webb PM; Risch HA; Modugno F, 2023, 'Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis', Journal of the National Cancer Institute, 115, pp. 539 - 551, http://dx.doi.org/10.1093/jnci/djad011

Pitiyarachchi O; Lee YC; Sim HW; Srirangan S; Mapagu C; Kirk J; Harnett PR; Balleine RL; Bowtell DDL; Samimi G; Brand AH; Marsh DJ; Beale P; Anderson L; Bouantoun N; Provan P; Ramus SJ; DeFazio A; Friedlander M, 2023, 'Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma', Translational Oncology, 31, http://dx.doi.org/10.1016/j.tranon.2023.101638

Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U, 2023, 'p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study', Journal of Pathology: Clinical Research, 9, pp. 208 - 222, http://dx.doi.org/10.1002/cjp2.311

Wang C; Block MS; Cunningham JM; Sherman ME; McCauley BM; Armasu SM; Vierkant RA; Traficante N; Talhouk A; Ramus SJ; Pejovic N; Kobel M; Jorgensen BD; Garsed DW; Fereday S; Doherty JA; Ariyaratne D; Anglesio MS; Widschwendter M; Pejovic T; Bosquet JG; Bowtell DD; Winham SJ; Goode EL, 2023, 'Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma', Cancer Epidemiology Biomarkers and Prevention, 32, pp. 542 - 549, http://dx.doi.org/10.1158/1055-9965.EPI-22-0941

Morra A; Mavaddat N; Muranen TA; Ahearn TU; Allen J; Andrulis IL; Auvinen P; Becher H; Behrens S; Blomqvist C; Bojesen SE; Bolla MK; Brauch H; Camp NJ; Carvalho S; Castelao JE; Cessna MH; Chang-Claude J; Chenevix-Trench G; Sahlberg KK; Børresen-Dale AL; Gram IT; Olsen KS; Engebråten O; Naume B; Geisler J; OSBREAC ; Grenaker Alnæs GI; Czene K; Decker B; Dennis J; Dörk T; Dorling L; Dunning AM; Ekici AB; Eriksson M; Evans DG; Fasching PA; Figueroa JD; Flyger H; Gago-Dominguez M; García-Closas M; Geurts-Giele WRR; Giles GG; Guénel P; Gündert M; Hahnen E; Hall P; Hamann U; Harrington PA; He W; Heikkilä P; Hooning MJ; Hoppe R; Howell A; Humphreys K; Amor D; Andrews L; Antill Y; Balleine R; Beesley J; Bennett I; Bogwitz M; Botes L; Brennan M; Brown M; Buckley M; Burke J; Butow P; Caldon L; Campbell I; Cao M; Chakrabarti A; Chauhan D; Chauhan M; Christian A; Cohen P; Colley A; Crook A; Cui J; Courtney E; Cummings M; Dawson SJ; DeFazio A; Delatycki M; Dickson R; Dixon J; Edkins T; Edwards S; Farshid G; Fellows A; Fenton G; Field M; Flanagan J; Fong P; Forrest L; Fox S; French J; Friedlander M; Gaff C, 2023, 'The impact of coding germline variants on contralateral breast cancer risk and survival', American Journal of Human Genetics, 110, pp. 475 - 486, http://dx.doi.org/10.1016/j.ajhg.2023.02.003

Kang EY; Weir A; Meagher NS; Farrington K; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Bolithon A; Popovic G; Leung B; Tang K; Lambie N; Millstein J; Alsop J; Anglesio MS; Ataseven B; Barlow E; Beckmann MW; Berger J; Bisinotto C; Bösmüller H; Boros J; Brand AH; Brooks-Wilson A; Brucker SY; Carney ME; Casablanca Y; Cazorla-Jiménez A; Cohen PA; Conrads TP; Cook LS; Coulson P; Courtney-Brooks M; Cramer DW; Crowe P; Cunningham JM; Cybulski C; Darcy KM; El-Bahrawy MA; Elishaev E; Erber R; Farrell R; Fereday S; Fischer A; García MJ; Gayther SA; Gentry-Maharaj A; Gilks CB; Grube M; Harnett PR; Harrington SP; Harter P; Hartmann A; Hecht JL; Heikaus S; Hein A; Heitz F; Hendley J; Hernandez BY; Polo SH; Heublein S; Hirasawa A; Høgdall E; Høgdall CK; Horlings HM; Huntsman DG; Huzarski T; Jewell A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Khabele D; Kommoss FKF; Kruitwagen RFPM; Lambrechts D; Le ND; Lener M; Lester J; Leung Y; Linder A; Loverix L; Lubiński J; Madan R; Maxwell GL; Modugno F; Neuhausen SL; Olawaiye A; Olbrecht S; Orsulic S; Palacios J; Pearce CL; Pike MC; Quinn CM; Mohan GR; Rodríguez-Antona C; Ruebner M; Ryan A; Salfinger SG, 2023, 'CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study', Cancer, 129, pp. 697 - 713, http://dx.doi.org/10.1002/cncr.34582

Hurwitz LM; Webb PM; Jordan SJ; Doherty JA; Harris HR; Goodman MT; Shvetsov YB; Modugno F; Moysich KB; Schildkraut JM; Berchuck A; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Wu AH; Pearce CL; Wentzensen N; Tworoger SS; Pharoah PDP; Trabert B, 2023, 'Association of Frequent Aspirin Use with Ovarian Cancer Risk According to Genetic Susceptibility', JAMA Network Open, 6, pp. E230666, http://dx.doi.org/10.1001/jamanetworkopen.2023.0666

Weir A; Kang EY; Meagher NS; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Gentry-Maharaj A; Ryan A; Singh N; Widschwendter M; Alsop J; Anglesio MS; Beckmann MW; Berger J; Bisinotto C; Boros J; Brand AH; Brenton JD; Brooks-Wilson A; Carney ME; Cunningham JM; Cushing-Haugen KL; Cybulski C; Elishaev E; Erber R; Fereday S; Fischer A; Paz-Ares L; Gayarre J; Gilks BC; Grube M; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Heublein S; Huang Y; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kommoss FKF; Koziak JM; Kraemer B; Le ND; Lesnock J; Lester J; Lubiński J; Menkiszak J; Ney B; Olawaiye A; Orsulic S; Osorio A; Robles-Díaz L; Ruebner M; Shah M; Sharma R; Shvetsov YB; Steed H; Talhouk A; Taylor SE; Traficante N; Vierkant RA; Wang C; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DDL; Candido dos Reis FJ; Cook LS; DeFazio A; DeFazio A; Harnett P; Doherty JA; Fasching PA; García MJ; Goode EL; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kommoss S; Modugno F; Schildkraut JM; Sinn HP; Staebler A; Kelemen LE; Ford CE; Menon U; Pharoah PDP; Köbel M; Ramus SJ, 2023, 'Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study', British Journal of Cancer, 128, pp. 137 - 147, http://dx.doi.org/10.1038/s41416-022-02014-y

Phung MT; Webb PM; DeFazio A; Fereday S; Lee AW; Bowtell DDL; Fasching PA; Goode EL; Goodman MT; Karlan BY; Lester J; Matsuo K; Modugno F; Brenton JD; Van Gorp T; Pharoah PDP; Schildkraut JM; McLean K; Meza R; Mukherjee B; Richardson J; Grout B; Chase A; McKinnon Deurloo C; Terry KL; Hanley GE; Pike MC; Berchuck A; Ramus SJ; Pearce CL, 2023, 'Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery', Gynecologic Oncology, 168, pp. 68 - 75, http://dx.doi.org/10.1016/j.ygyno.2022.10.018

Meagher NS; Hamilton P; Milne K; Thornton S; Harris B; Weir A; Alsop J; Bisinoto C; Brenton JD; Brooks-Wilson A; Chiu DS; Cushing-Haugen KL; Fereday S; Garsed DW; Gayther SA; Gentry-Maharaj A; Gilks B; Jimenez-Linan M; Kennedy CJ; Le ND; Piskorz AM; Riggan MJ; Shah M; Singh N; Talhouk A; Widschwendter M; Bowtell DDL; Candido dos Reis FJ; Cook LS; Fortner RT; García MJ; Harris HR; Huntsman DG; Karnezis AN; Köbel M; Menon U; Pharoah PDP; Doherty JA; Anglesio MS; Pike MC; Pearce CL; Friedlander ML; DeFazio A; Nelson BH; Ramus SJ, 2023, 'Profiling the immune landscape in mucinous ovarian carcinoma', Gynecologic Oncology, 168, pp. 23 - 31, http://dx.doi.org/10.1016/j.ygyno.2022.10.022

Hurwitz LM; Townsend MK; Jordan SJ; Patel AV; Teras LR; Lacey JV; Doherty JA; Harris HR; Goodman MT; Shvetsov YB; Modugno F; Moysich KB; Robien K; Prizment A; Schildkraut JM; Berchuck A; Fortner RT; Chan AT; Wentzensen N; Hartge P; Sandler DP; O'Brien KM; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Pearce CL; Wu AH; White E; Peters U; Webb PM; Tworoger SS; Trabert B, 2022, 'Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia', Journal of Clinical Oncology, 40, pp. 4207 - 4217, http://dx.doi.org/10.1200/JCO.21.01900

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubinski J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F, 2022, 'Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes', Clinical Cancer Research, 28, pp. 5383 - 5395, http://dx.doi.org/10.1158/1078-0432.CCR-22-1206

Garsed DW; Pandey A; Fereday S; Kennedy CJ; Takahashi K; Alsop K; Hamilton PT; Hendley J; Chiew YE; Traficante N; Provan P; Ariyaratne D; Au-Yeung G; Bateman NW; Bowes L; Brand A; Christie EL; Cunningham JM; Friedlander M; Grout B; Harnett P; Hung J; McCauley B; McNally O; Piskorz AM; Saner FAM; Vierkant RA; Wang C; Winham SJ; Pharoah PDP; Brenton JD; Conrads TP; Maxwell GL; Ramus SJ; Pearce CL; Pike MC; Nelson BH; Goode EL; DeFazio A; Bowtell DDL, 2022, 'The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer', Nature Genetics, 54, pp. 1853 - 1864, http://dx.doi.org/10.1038/s41588-022-01230-9

Devries AA; Dennis J; Tyrer JP; Peng PC; Coetzee SG; Reyes AL; Plummer JT; Davis BD; Chen SS; Dezem FS; Aben KKH; Anton-Culver H; Antonenkova NN; Beckmann MW; Beeghly-Fadiel A; Berchuck A; Bogdanova NV; Bogdanova-Markov N; Brenton JD; Butzow R; Campbell I; Chang-Claude J; Chenevix-Trench G; Cook LS; Defazio A; Doherty JA; Dork T; Eccles DM; Eliassen AH; Fasching PA; Fortner RT; Giles GG; Goode EL; Goodman MT; Gronwald J; Hakansson N; Hildebrandt MAT; Huff C; Huntsman DG; Jensen A; Kar S; Karlan BY; Khusnutdinova EK; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Labrie M; Lambrechts D; Le ND; Lubinski J; May T; Menon U; Milne RL; Modugno F; Monteiro AN; Moysich KB; Odunsi K; Olsson H; Pearce CL; Pejovic T; Ramus SJ; Riboli E; Riggan MJ; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Sieh W; Song H; Sutphen R; Terry KL; Thompson PJ; Titus L; Tworoger SS; Van Nieuwenhuysen E; Edwards DV; Webb PM; Wentzensen N; Whittemore AS; Wolk A; Wu AH; Ziogas A; Freedman ML; Lawrenson K; Pharoah PDP; Easton DF; Gayther SA; Jones MR, 2022, 'Copy number variants are ovarian cancer risk alleles at known and novel risk loci', Journal of the National Cancer Institute, 114, pp. 1533 - 1544, http://dx.doi.org/10.1093/jnci/djac160

Kumar A; Wang C; Sheedy SP; McCauley BM; Winham SJ; Ramus SJ; Anglesio MS; Kim B; Torres D; Keeney GL; Cliby WA; Goode EL, 2022, 'Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer', Gynecologic Oncology, 166, pp. 508 - 514, http://dx.doi.org/10.1016/j.ygyno.2022.07.020

Lee A; Yang X; Tyrer J; Gentry-Maharaj A; Ryan A; Mavaddat N; Cunningham AP; Carver T; Archer S; Leslie G; Kalsi J; Gaba F; Manchanda R; Gayther S; Ramus SJ; Walter FM; Tischkowitz M; Jacobs I; Menon U; Easton DF; Pharoah P; Antoniou AC, 2022, 'Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors', Journal of Medical Genetics, 59, pp. 632 - 643, http://dx.doi.org/10.1136/jmedgenet-2021-107904

Li S; Silvestri V; Leslie G; Rebbeck TR; Neuhausen SL; Hopper JL; Nielsen HR; Lee A; Yang X; Mcguffog L; Parsons MT; Andrulis IL; Arnold N; Belotti M; Borg Å; Buecher B; Buys SS; Caputo SM; Chung WK; Colas C; Colonna SV; Cook J; Daly MB; De La Hoya M; De Pauw A; Delhomelle H; Eason J; Engel C; Evans DG; Faust U; Fehm TN; Fostira F; Fountzilas G; Frone M; Garcia-Barberan V; Garre P; Gauthier-Villars M; Gehrig A; Glendon G; Goldgar DE; Golmard L; Greene MH; Hahnen E; Hamann U; Hanson H; Hassan T; Hentschel J; Horvath J; Izatt L; Janavicius R; Jiao Y; John EM; Karlan BY; Kim SW; Konstantopoulou I; Kwong A; Laugé A; Lee JW; Lesueur F; Mebirouk N; Meindl A; Mouret-Fourme E; Musgrave H; Ngeow Yuen Yie J; Niederacher D; Park SK; Pedersen IS; Ramser J; Ramus SJ; Rantala J; Rashid MU; Reichl F; Ritter J; Rump A; Santamariña M; Saule C; Schmidt G; Schmutzler RK; Senter L; Shariff S; Singer CF; Southey MC; Stoppa-Lyonnet D; Sutter C; Tan Y; Teo SH; Terry MB; Thomassen M; Tischkowitz M; Toland AE; Torres D; Vega A; Wagner SA; Wang-Gohrke S; Wappenschmidt B; Weber BHF; Yannoukakos D; Spurdle AB; Easton DF; Chenevix-Trench G, 2022, 'Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants', Journal of Clinical Oncology, 40, pp. 1529 - 1541, http://dx.doi.org/10.1200/JCO.21.02112

Kang EY; Millstein J; Popovic G; Meagher NS; Bolithon A; Talhouk A; Chiu DS; Anglesio MS; Leung B; Tang K; Lambie N; Pavanello M; Da-anoy A; Lambrechts D; Loverix L; Olbrecht S; Bisinotto C; Garcia-Donas J; Ruiz-Llorente S; Yagüe-Fernandez M; Edwards RP; Elishaev E; Olawaiye A; Taylor S; Ataseven B; du Bois A; Harter P; Lester J; Høgdall CK; Armasu SM; Huang Y; Vierkant RA; Wang C; Winham SJ; Heublein S; Kommoss FKF; Cramer DW; Sasamoto N; van-Wagensveld L; Lycke M; Mateoiu C; Joseph J; Pike MC; Odunsi K; Tseng CC; Pearce CL; Bilic S; Conrads TP; Hartmann A; Hein A; Jones ME; Leung Y; Beckmann MW; Ruebner M; Schoemaker MJ; Terry KL; El-Bahrawy MA; Coulson P; Etter JL; LaVigne-Mager K; Andress J; Grube M; Fischer A; Neudeck N; Robertson G; Farrell R; Barlow E; Quinn C; Hettiaratchi A; Casablanca Y; Erber R; Stewart CJR; Tan A; Yu Y; Boros J; Brand AH; Harnett PR; Kennedy CJ; Nevins N; Morgan T; Fasching PA; Vergote I; Swerdlow AJ; Candido dos Reis FJ; Maxwell GL; Neuhausen SL; Barquin-Garcia A; Modugno F; Moysich KB; Crowe PJ; Hirasawa A; Heitz F; Karlan BY; Goode EL; Sinn P; Horlings HM; Høgdall E; Sundfeldt K; Kommoss S; Staebler A, 2022, 'MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma', Virchows Archiv, 480, pp. 855 - 871, http://dx.doi.org/10.1007/s00428-021-03232-0

Heinze K; Nazeran TM; Lee S; Krämer P; Cairns ES; Chiu DS; Leung SCY; Kang EY; Meagher NS; Kennedy CJ; Boros J; Kommoss F; Vollert HW; Heitz F; du Bois A; Harter P; Grube M; Kraemer B; Staebler A; Kommoss FKF; Heublein S; Sinn HP; Singh N; Laslavic A; Elishaev E; Olawaiye A; Moysich K; Modugno F; Sharma R; Brand AH; Harnett PR; DeFazio A; Fortner RT; Lubinski J; Lener M; Tołoczko-Grabarek A; Cybulski C; Gronwald H; Gronwald J; Coulson P; El-Bahrawy MA; Jones ME; Schoemaker MJ; Swerdlow AJ; Gorringe KL; Campbell I; Cook L; Gayther SA; Carney ME; Shvetsov YB; Hernandez BY; Wilkens LR; Goodman MT; Mateoiu C; Linder A; Sundfeldt K; Kelemen LE; Gentry-Maharaj A; Widschwendter M; Menon U; Bolton KL; Alsop J; Shah M; Jimenez-Linan M; Pharoah PDP; Brenton JD; Cushing-Haugen KL; Harris HR; Doherty JA; Gilks B; Ghatage P; Huntsman DG; Nelson GS; Tinker AV; Lee CH; Goode EL; Nelson BH; Ramus SJ; Kommoss S; Talhouk A; Köbel M; Anglesio MS, 2022, 'Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8⁺ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas', Journal of Pathology, 256, pp. 388 - 401, http://dx.doi.org/10.1002/path.5849

Dareng EO; Tyrer JP; Barnes DR; Jones MR; Yang X; Aben KKH; Adank MA; Agata S; Andrulis IL; Anton-Culver H; Antonenkova NN; Aravantinos G; Arun BK; Augustinsson A; Balmana J; Bandera EV; Barkardottir RB; Barrowdale D; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Bjorge L; Black A; Bogdanova NV; Bonanni B; Borg A; Brenton JD; Budzilowska A; Butzow R; Buys SS; Cai H; Caligo MA; Campbell I; Cannioto R; Cassingham H; Chang-Claude J; Chanock SJ; Chen K; Chiew Y-E; Chung WK; Claes KBM; Colonna S; Cook LS; Couch FJ; Daly MB; Dao F; Davies E; de la Hoya M; de Putter R; Dennis J; DePersia A; Devilee P; Diez O; Ding YC; Doherty JA; Domchek SM; Dork T; du Bois A; Durst M; Eccles DM; Eliassen HA; Engel C; Evans GD; Fasching PA; Flanagan JM; Fortner RT; Machackova E; Friedman E; Ganz PA; Garber J; Gensini F; Giles GG; Glendon G; Godwin AK; Goodman MT; Greene MH; Gronwald J; Hahnen E; Haiman CA; Hakansson N; Hamann U; Hansen TVO; Harris HR; Hartman M; Heitz F; Hildebrandt MAT; Hogdall E; Hogdall CK; Hopper JL; Huang R-Y; Huff C; Hulick PJ; Huntsman DG; Imyanitov EN; Isaacs C; Jakubowska A; James PA; Janavicius R; Jensen A; Johannsson OT; John EM; Jones ME; Kang D; Karlan BY; Karnezis A; Kelemen LE; Khusnutdinova E; Kiemeney LA; Kim B-G; Kjaer SK; Komenaka I; Kupryjanczyk J; Kurian AW; Kwong A; Lambrechts D; Larson MC; Lazaro C; Le ND; Leslie G; Lester J; Lesueur F; Levine DA; Li L; Li J; Loud JT; Lu KH; Lubinski J; Mai PL; Manoukian S; Marks JR; Matsuno RK; Matsuo K; May T; McGuffog L; McLaughlin JR; McNeish IA; Mebirouk N; Menon U; Miller A; Milne RL; Minlikeeva A; Modugno F; Montagna M; Moysich KB; Munro E; Nathanson KL; Neuhausen SL; Nevanlinna H; Yie JNY; Nielsen HR; Nielsen FC; Nikitina-Zake L; Odunsi K; Offit K; Olah E; Olbrecht S; Olopade OI; Olson SH; Olsson H; Osorio A; Papi L; Park SK; Parsons MT; Pathak H; Pedersen IS; Peixoto A; Pejovic T; Perez-Segura P; Permuth JB; Peshkin B; Peterlongo P; Piskorz A; Prokofyeva D; Radice P; Rantala J; Riggan MJ; Risch HA; Rodriguez-Antona C; Ross E; Rossing MA; Runnebaum I; Sandler DP; Santamarina M; Soucy P; Schmutzler RK; Setiawan VW; Shan K; Sieh W; Simard J; Singer CF; Sokolenko AP; Song H; Southey MC; Steed H; Stoppa-Lyonnet D; Sutphen R; Swerdlow AJ; Tan YY; Teixeira MR; Teo SH; Terry KL; Terry MB; Thomassen M; Thompson PJ; Thomsen LCV; Thull DL; Tischkowitz M; Titus L; Toland AE; Torres D; Trabert B; Travis R; Tung N; Tworoger SS; Valen E; van Altena AM; van der Hout AH; Van Nieuwenhuysen E; van Rensburg EJ; Vega A; Edwards DV; Vierkant RA; Wang F; Wappenschmidt B; Webb PM; Weinberg CR; Weitzel JN; Wentzensen N; White E; Whittemore AS; Winham SJ; Wolk A; Woo Y-L; Wu AH; Yan L; Yannoukakos D; Zavaglia KM; Zheng W; Ziogas A; Zorn KK; Kleibl Z; Easton D; Lawrenson K; DeFazio A; Sellers TA; Ramus SJ; Pearce CL; Monteiro AN; Cunningham JM; Goode EL; Schildkraut JM; Berchuck A; Chenevix-Trench G; Gayther SA; Antoniou AC; Pharoah PDP, 2022, 'Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)', EUROPEAN JOURNAL OF HUMAN GENETICS, 30, pp. 630 - 631, http://dx.doi.org/10.1038/s41431-022-01085-y

Dareng EO; Tyrer JP; Barnes DR; Jones MR; Yang X; Aben KKH; Adank MA; Agata S; Andrulis IL; Anton-Culver H; Antonenkova NN; Aravantinos G; Arun BK; Augustinsson A; Balmaña J; Bandera EV; Barkardottir RB; Barrowdale D; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Bjorge L; Black A; Bogdanova NV; Bonanni B; Borg A; Brenton JD; Budzilowska A; Butzow R; Buys SS; Cai H; Caligo MA; Campbell I; Cannioto R; Cassingham H; Chang-Claude J; Chanock SJ; Chen K; Chiew YE; Chung WK; Claes KBM; Colonna S; Cook LS; Couch FJ; Daly MB; Dao F; Davies E; de la Hoya M; de Putter R; Dennis J; DePersia A; Devilee P; Diez O; Ding YC; Doherty JA; Domchek SM; Dörk T; du Bois A; Dürst M; Eccles DM; Eliassen HA; Engel C; Evans GD; Fasching PA; Flanagan JM; Fortner RT; Machackova E; Friedman E; Ganz PA; Garber J; Gensini F; Giles GG; Glendon G; Godwin AK; Goodman MT; Greene MH; Gronwald J; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hansen TVO; Harris HR; Hartman M; Heitz F; Hildebrandt MAT; Høgdall E; Høgdall CK; Hopper JL; Huang RY; Huff C; Hulick PJ; Huntsman DG; Imyanitov EN; van der Hout AH; Isaacs C; Jakubowska A; James PA, 2022, 'Polygenic risk modeling for prediction of epithelial ovarian cancer risk', European Journal of Human Genetics, 30, pp. 349 - 362, http://dx.doi.org/10.1038/s41431-021-00987-7

Brieger KK; Phung MT; Mukherjee B; Bakulski KM; Anton-Culver H; Bandera EV; Bowtell DDL; Cramer DW; DeFazio A; Doherty JA; Fereday S; Fortner RT; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Matsuo K; Menon U; Modugno F; Moysich KB; Qin B; Ramus SJ; Risch HA; Rossing MA; Schildkraut JM; Trabert B; Vierkant RA; Winham SJ; Wentzensen N; Wu AH; Ziogas A; Khoja L; Cho KR; McLean K; Richardson J; Grout B; Chase A; McKinnon Deurloo C; Odunsi K; Nelson BH; Brenton JD; Terry KL; Pharoah PDP; Berchuck A; Hanley GE; Webb PM; Pike MC; Pearce CL, 2022, 'High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival', Cancer Epidemiology Biomarkers and Prevention, 31, pp. 443 - 452, http://dx.doi.org/10.1158/1055-9965.EPI-21-0977

Xu X; Wang Y; Bryce NS; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents', British Journal of Cancer, 125, pp. 265 - 276, http://dx.doi.org/10.1038/s41416-021-01420-y

Kar SP; Considine DPC; Tyrer JP; Plummer JT; Chen S; Dezem FS; Barbeira AN; Rajagopal PS; Rosenow WT; Moreno F; Bodelon C; Chang-Claude J; Chenevix-Trench G; deFazio A; Dörk T; Ekici AB; Ewing A; Fountzilas G; Goode EL; Hartman M; Heitz F; Hillemanns P; Høgdall E; Høgdall CK; Huzarski T; Jensen A; Karlan BY; Khusnutdinova E; Kiemeney LA; Kjaer SK; Klapdor R; Köbel M; Li J; Liebrich C; May T; Olsson H; Permuth JB; Peterlongo P; Radice P; Ramus SJ; Riggan MJ; Risch HA; Saloustros E; Simard J; Szafron LM; Titus L; Thompson CL; Vierkant RA; Winham SJ; Zheng W; Doherty JA; Berchuck A; Lawrenson K; Im HK; Manichaikul AW; Pharoah PDP; Gayther SA; Schildkraut JM, 2021, 'Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer', Human Genetics and Genomics Advances, 2, http://dx.doi.org/10.1016/j.xhgg.2021.100042

Song H; Dicks EM; Tyrer J; Intermaggio M; Chenevix-Trench G; Bowtell DD; Traficante N; Group A; Brenton J; Goranova T; Hosking K; Piskorz A; Van Oudenhove E; Doherty J; Harris HR; Rossing MA; Duerst M; Dork T; Bogdanova NV; Modugno F; Moysich K; Odunsi K; Ness R; Karlan BY; Lester J; Jensen A; Krüger Kjaer S; Høgdall E; Campbell IG; Lázaro C; Pujara MA; Cunningham J; Vierkant R; Winham SJ; Hildebrandt M; Huff C; Li D; Wu X; Yu Y; Permuth JB; Levine DA; Schildkraut JM; Riggan MJ; Berchuck A; Webb PM; Group OS; Cybulski C; Gronwald J; Jakubowska A; Lubinski J; Alsop J; Harrington P; Chan I; Menon U; Pearce CL; Wu AH; De Fazio A; Kennedy CJ; Goode E; Ramus S; Gayther S; Pharoah P, 2021, 'Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer', Journal of Medical Genetics, 58, pp. 305 - 313, http://dx.doi.org/10.1136/jmedgenet-2019-106739

Lee AW; Rosenzweig S; Wiensch A; Ramus SJ; Menon U; Gentry-Maharaj A; Ziogas A; Anton-Culver H; Whittemore AS; Sieh W; Rothstein JH; Mcguire V; Wentzensen N; Bandera EV; Qin B; Terry KL; Cramer DW; Titus L; Schildkraut JM; Berchuck A; Goode EL; Kjaer SK; Jensen A; Jordan SJ; Ness RB; Modugno F; Moysich K; Thompson PJ; Goodman MT; Carney ME; Chang-Claude J; Rossing MA; Harris HR; Doherty JA; Risch HA; Khoja L; Alimujiang A; Phung MT; Brieger K; Mukherjee B; Pharoah PDP; Wu AH; Pike MC; Webb PM; Pearce CL, 2021, 'Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies', Journal of the National Cancer Institute, 113, pp. 301 - 308, http://dx.doi.org/10.1093/jnci/djaa099

Glubb DM; Thompson DJ; Aben KKH; Alsulimani A; Amant F; Annibali D; Attia J; Barricarte A; Beckmann MW; Berchuck A; Bermisheva M; Bernardini MQ; Bischof K; Bjorge L; Bodelon C; Brand AH; Brenton JD; Brinton LA; Bruinsma F; Buchanan DD; Burghaus S; Butzow R; Cai H; Carney ME; Chanock SJ; Chen C; Chen XQ; Chen Z; Cook LS; Cunningham JM; De Vivo I; deFazio A; Doherty JA; Dörk T; du Bois A; Dunning AM; Dürst M; Edwards T; Edwards RP; Ekici AB; Ewing A; Fasching PA; Ferguson S; Flanagan JM; Fostira F; Fountzilas G; Friedenreich CM; Gao B; Gaudet MM; Gawełko J; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harris HR; Harter P; Hein A; Heitz F; Hildebrandt MAT; Hillemanns P; Høgdall E; Høgdall CK; Holliday EG; Huntsman DG; Huzarski T; Jakubowska A; Jensen A; Jones ME; Karlan BY; Karnezis A; Kelley JL; Khusnutdinova E; Killeen JL; Kjaer SK; Klapdor R; Köbel M; Konopka B; Konstantopoulou I; Kopperud RK; Koti M; Kraft P; Kupryjanczyk J; Lambrechts D; Larson MC; Le Marchand L; Lele S; Lester J; Li AJ; Liang D; Liebrich C; Lipworth L; Lissowska J; Lu L; Lu KH; Macciotta A; Mattiello A; May T; McAlpine JN; McGuire V, 2021, 'Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers', Cancer Epidemiology Biomarkers and Prevention, 30, pp. 217 - 228, http://dx.doi.org/10.1158/1055-9965.EPI-20-0739

Kang EY; Cheasley D; LePage C; Wakefield MJ; da Cunha Torres M; Rowley S; Salazar C; Xing Z; Allan P; Bowtell DDL; Mes-Masson AM; Provencher DM; Rahimi K; Kelemen LE; Fasching PA; Doherty JA; Goodman MT; Goode EL; Deen S; Pharoah PDP; Brenton JD; Sieh W; Mateoiu C; Sundfeldt K; Cook LS; Le ND; Anglesio MS; Gilks CB; Huntsman DG; Kennedy CJ; Traficante N; Chenevix-Trench G; Green A; Webb P; De Fazio A; Gertig D; Fereday S; Moore S; Hung J; Harrap K; Sadkowsky T; Pandeya N; Malt M; Mellon A; Robertson R; Bergh TV; Jones M; Mackenzie P; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Ferguson K; Martin K; Martyn A; Ranieri B; White J; Jayde V; Mamers P; Bowes L; Galletta L; Giles D; Hendley J; Alsop K; Schmidt T; Shirley H; Ball C; Young C; Viduka S; Tran H; Bilic S; Glavinas L; Brooks J; Stuart-Harris R; Kirsten F; Rutovitz J; Clingan P; Glasgow A; Proietto A; Braye S; Otton G; Shannon J; Bonaventura T; Stewart J; Begbie S; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Pavlakis N, 2021, 'Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses', Modern Pathology, 34, pp. 194 - 206, http://dx.doi.org/10.1038/s41379-020-0618-9

Yang X; Song H; Leslie G; Engel C; Hahnen E; Auber B; Horváth J; Kast K; Niederacher D; Turnbull C; Houlston R; Hanson H; Loveday C; Dolinsky JS; Laduca H; Ramus SJ; Menon U; Rosenthal AN; Jacobs I; Gayther SA; DIcks E; Nevanlinna H; Aittomäki K; Pelttari LM; Ehrencrona H; Borg Å; Kvist A; Rivera B; Hansen TVO; Djursby M; Lee A; Dennis J; Bowtell DD; Traficante N; DIez O; Balmaña J; Gruber SB; Chenevix-Trench G; Investigators K; Jensen A; Kjær SK; Høgdall E; Castéra L; Garber J; Janavicius R; Osorio A; Golmard L; Vega A; Couch FJ; Robson M; Gronwald J; Domchek SM; Culver JO; De La Hoya M; Easton DF; Foulkes WD; Tischkowitz M; Meindl A; Schmutzler RK; Pharoah PDP; Antoniou AC, 2020, 'Ovarian and Breast Cancer Risks Associated with Pathogenic Variants in RAD51C and RAD51D', Journal of the National Cancer Institute, 112, pp. 1242 - 1250, http://dx.doi.org/10.1093/jnci/djaa030

Modugno F; Fu Z; Jordan SJ; Group A; Chang-Claude J; Fortner RT; Goodman MT; Moysich KB; Schildkraut JM; Berchuck A; Bandera EV; Qin B; Sutphen R; McLaughlin JR; Menon U; Ramus SJ; Gayther SA; Gentry-Maharaj A; Karpinskyj C; Pearce CL; Wu AH; Risch HA; Webb PM, 2020, 'Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case–control studies', European Journal of Epidemiology, 35, pp. 1025 - 1042, http://dx.doi.org/10.1007/s10654-020-00682-9

Talhouk A; George J; Wang C; Budden T; Tan TZ; Chiu DS; Kommoss S; Leong HS; Chen S; Intermaggio MP; Gilks B; Nazeran TM; Volchek M; Elatre W; Bentley RC; Senz J; Lum A; Chow V; Sudderuddin H; Mackenzie R; Leong SCY; Liu G; Johnson D; Chen B; Alsop J; Banerjee SN; Behrens S; Bodelon C; Brand AH; Brinton L; Carney ME; Chiew YE; Cushing-Haugen KL; Cybulski C; Ennis D; Fereday S; Fortner RT; García-Donas J; Gentry-Maharaj A; Glasspool R; Goranova T; Greene CS; Haluska P; Harris HR; Hendley J; Hernandez BY; Herpel E; Jimenez-Linan M; Karpinskyj C; Kaufmann SH; Keeney GL; Kennedy CJ; Kobel M; Koziak JM; Larson MC; Lester J; Lewsley LA; Lissowska J; Lubiński J; Luk H; Macintyre G; Mahner S; McNeish IA; Menkiszak J; Nevins N; Osorio A; Oszurek O; Palacios J; Hinsley S; Pearce CL; Pike MC; Piskorz AM; Ray-Coquard I; Rhenius V; Rodriguez-Antona C; Sharma R; Sherman ME; de Silva D; Singh N; Sinn P; Slamon D; Song H; Steed H; Stronach EA; Thompson PJ; Tołoczko A; Trabert B; Traficante N; Tseng CC; Widschwendter M; Wilkens LR; Winham SJ; Winterhoff B; Beeghly-Fadiel A; Benitez J; Berchuck A; Brenton JD; Brown R; Chang-Claude J; Chenevix-Trench G, 2020, 'Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE)', Clinical Cancer Research, 26, pp. 5411 - 5423, http://dx.doi.org/10.1158/1078-0432.CCR-20-0103

Barnes DR; Rookus MA; McGuffog L; Leslie G; Mooij TM; Dennis J; Mavaddat N; Adlard J; Ahmed M; Aittomäki K; Andrieu N; Andrulis IL; Arnold N; Arun BK; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Benitez J; Berthet P; Białkowska K; Blanco AM; Blok MJ; Bonanni B; Boonen SE; Borg Å; Bozsik A; Bradbury AR; Brennan P; Brewer C; Brunet J; Buys SS; Caldés T; Caligo MA; Campbell I; Christensen LL; Chung WK; Claes KBM; Colas C; Collonge-Rame MA; Delnatte C; Faivre L; Giraud S; Lasset C; Mari V; Mebirouk N; Mouret-Fourme E; Schuster H; Stoppa-Lyonnet D; Antoniou A; Cook J; Davidson R; Easton D; Eeles R; Evans DG; Frost D; Hanson H; Izatt L; Ong KR; Side L; O’Shaughnessy-Kirwan A; Tischkowitz M; Walker L; Daly MB; de la Hoya M; de Putter R; Devilee P; Diez O; Ding YC; Domchek SM; Dorfling CM; Dumont M; Ejlertsen B; Engel C; Foretova L; Fostira F; Friedlander M; Friedman E; Ganz PA; Garber J; Gehrig A; Gerdes AM; Gesta P; Glendon G; Godwin AK; Goldgar DE, 2020, 'Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants', Genetics in Medicine, 22, pp. 1653 - 1666, http://dx.doi.org/10.1038/s41436-020-0862-x

Pavanello M; Chan IHY; Ariff A; Pharoah PDP; Gayther SA; Ramus SJ, 2020, 'Rare germline genetic variants and the risks of epithelial ovarian cancer', Cancers, 12, pp. 1 - 23, http://dx.doi.org/10.3390/cancers12103046

Martins FC; Couturier DL; Paterson A; Karnezis AN; Chow C; Nazeran TM; Odunsi A; Gentry-Maharaj A; Vrvilo A; Hein A; Talhouk A; Osorio A; Hartkopf AD; Brooks-Wilson A; DeFazio A; Fischer A; Hartmann A; Hernandez BY; McCauley BM; Karpinskyj C; de Sousa CB; Høgdall C; Tiezzi DG; Herpel E; Taran FA; Modugno F; Keeney G; Nelson G; Steed H; Song H; Luk H; Benitez J; Alsop J; Koziak JM; Lester J; Rothstein JH; de Andrade JM; Lundvall L; Paz-Ares L; Robles-Díaz L; Wilkens LR; Garcia MJ; Intermaggio MP; Alcaraz ML; Brett MA; Beckmann MW; Jimenez-Linan M; Anglesio M; Carney ME; Schneider M; Traficante N; Pejovic N; Singh N; Le N; Sinn P; Ghatage P; Erber R; Edwards R; Vierkant R; Ness RB; Leung S; Orsulic S; Brucker SY; Kaufmann SH; Fereday S; Gayther S; Winham SJ; Kommoss S; Pejovic T; Longacre TA; McGuire V; Rhenius V; Sieh W; Shvetsov YB; Whittemore AS; Staebler A; Karlan BY; Rodriguez-Antona C; Bowtell DD; Goode EL; Høgdall E; Candido dos Reis FJ; Gronwald J; Chang-Claude J; Moysich KB; Kelemen LE; Cook LS; Goodman MT; Fasching PA; Crawford R; Deen S; Menon U; Huntsman DG; Köbel M; Ramus SJ; Pharoah PDP; Brenton JD, 2020, 'Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium', British Journal of Cancer, 123, pp. 793 - 802, http://dx.doi.org/10.1038/s41416-020-0900-0

Brieger KK; Peterson S; Lee AW; Mukherjee B; Bakulski KM; Alimujiang A; Anton-Culver H; Anglesio MS; Bandera EV; Berchuck A; Bowtell DDL; Chenevix-Trench G; Cho KR; Cramer DW; DeFazio A; Doherty JA; Fortner RT; Garsed DW; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Høgdall E; Huntsman DG; Shen H; Jensen A; Johnatty SE; Jordan SJ; Kjaer SK; Kupryjanczyk J; Lambrechts D; McLean K; Menon U; Modugno F; Moysich K; Ness R; Ramus SJ; Richardson J; Risch H; Rossing MA; Trabert B; Wentzensen N; Ziogas A; Terry KL; Wu AH; Hanley GE; Pharoah P; Webb PM; Pike MC; Pearce CL, 2020, 'Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival', Gynecologic Oncology, 158, pp. 702 - 709, http://dx.doi.org/10.1016/j.ygyno.2020.06.481

Millstein J; Budden T; Goode EL; Anglesio MS; Talhouk A; Intermaggio MP; Leong HS; Chen S; Elatre W; Gilks B; Nazeran T; Volchek M; Bentley RC; Wang C; Chiu DS; Kommoss S; Leung SCY; Senz J; Lum A; Chow V; Sudderuddin H; Mackenzie R; George J; Bowtell DD; Chenevix-Trench G; Green A; Webb P; deFazio A; Gertig D; Traficante N; Fereday S; Moore S; Hung J; Harrap K; Sadkowsky T; Pandeya N; Malt M; Mellon A; Robertson R; Vanden Bergh T; Jones M; Mackenzie P; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Ferguson K; Martin K; Martyn A; Ranieri B; White J; Jayde V; Mamers P; Bowes L; Galletta L; Giles D; Hendley J; Alsop K; Schmidt T; Shirley H; Ball C; Young C; Viduka S; Tran H; Bilic S; Glavinas L; Brooks J; Stuart-Harris R; Kirsten F; Rutovitz J; Clingan P; Glasgow A; Proietto A; Braye S; Otton G; Shannon J; Bonaventura T; Stewart J; Begbie S; Friedlander M; Bell D; Baron-Hay S; Ferrier,a A; Gard G; Nevell D; Pavlakis N; Valmadre S; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D, 2020, 'Prognostic gene expression signature for high-grade serous ovarian cancer', Annals of Oncology, 31, pp. 1240 - 1250, http://dx.doi.org/10.1016/j.annonc.2020.05.019

Zhang H; Ahearn TU; Lecarpentier J; Barnes D; Beesley J; Qi G; Jiang X; O’Mara TA; Zhao N; Bolla MK; Dunning AM; Dennis J; Wang Q; Ful ZA; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Aronson KJ; Arun BK; Auer PL; Azzollini J; Barrowdale D; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bialkowska K; Blanco A; Blomqvist C; Bogdanova NV; Bojesen SE; Bonanni B; Bondavalli D; Borg A; Brauch H; Brenner H; Briceno I; Broeks A; Brucker SY; Brüning T; Burwinkel B; Buys SS; Byers H; Caldés T; Caligo MA; Calvello M; Campa D; Castelao JE; Chang-Claude J; Chanock SJ; Christiaens M; Christiansen H; Chung WK; Claes KBM; Clarke CL; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Diez O; Domchek SM; Dörk T; Dwek M; Eccles DM; Ekici AB; Evans DG; Fasching PA; Figueroa J; Foretova L; Fostira F; Friedman E; Frost D; Gago-Dominguez M; Gapstur SM; Garber J; García-Sáenz JA; Gaudet MM; Gayther SA; Giles GG; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Greene MH; Gronwald J; Guénel P; Häberle L; Hahnen E; Haiman CA; Hake CR; Hall P; Hamann U; Harkness EF; Heemskerk-Gerritsen BAM; Hillemanns P, 2020, 'Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses', Nature Genetics, 52, pp. 572 - 581, http://dx.doi.org/10.1038/s41588-020-0609-2

Yang X; Leslie G; Doroszuk A; Schneider S; Allen J; Decker B; Dunning AM; Redman J; Scarth J; Plaskocinska I; Luccarini C; Shah M; Pooley K; Dorling L; Leei A; Adank MA; Adlard J; Aittomäki K; Andrulis IL; Ang P; Barwell J; Bernstein JL; Bobolis K; Borg Å; Blomqvist C; Claes KBM; Concannon P; Cuggia A; Culver JO; Damiola F; De Pauw A; Diez O; Dolinsky JS; Domchek SM; Engel C; Evans DG; Fostira F; Garber J; Golmard L; Goode EL; Gruber SB; Hahnen E; Hake C; Heikkinen T; Hurley JE; Janavicius R; Kleibl Z; Kleiblova P; Konstantopoulou I; Kvist A; Laduca H; Lee ASG; Lesueur F; Maher ER; Mannermaa A; Manoukian S; McFarland R; McKinnon W; Meindl A; Metcalfe K; Taib NAM; Moilanen J; Nathanson KL; Neuhausen S; Ng PS; Nguyen-Dumont T; Nielsen SM; Obermair F; Offit K; Olopade OI; Ottini L; Penkert J; Pylkäs K; Radice P; Ramus SJ; Rudaitis V; Side L; Silva-Smith R; Silvestri V; Skytte AB; Slavin T; Soukupova J; Tondini C; Trainer AH; Unzeitig G; Usha L; Van Overeem Hansen T; Whitworth J; Wood M; Yip CH; Yoon SY; Yussuf A; Zogopoulos G; Goldgar D; Hopper JL; Chenevix-Trench G; Pharoah P; George SHL; Balmaña J; Houdayer C, 2020, 'Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families', Journal of Clinical Oncology, 38, pp. 674 - 685, http://dx.doi.org/10.1200/JCO.19.01907

Fachal L; Aschard H; Beesley J; Barnes DR; Allen J; Kar S; Pooley KA; Dennis J; Michailidou K; Turman C; Soucy P; Lemaçon A; Lush M; Tyrer JP; Ghoussaini M; Marjaneh MM; Jiang X; Agata S; Aittomäki K; Alonso MR; Andrulis IL; Anton-Culver H; Antonenkova NN; Arason A; Arndt V; Aronson KJ; Arun BK; Auber B; Auer PL; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bialkowska K; Blanco AM; Blomqvist C; Blot W; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Borg A; Bosse K; Brauch H; Brenner H; Briceno I; Brock IW; Brooks-Wilson A; Brüning T; Burwinkel B; Buys SS; Cai Q; Caldés T; Caligo MA; Camp NJ; Campbell I; Canzian F; Carroll JS; Carter BD; Castelao JE; Chiquette J; Christiansen H; Chung WK; Claes KBM; Clarke CL; Mari V; Berthet P; Castera L; Vaur D; Lallaoui H; Bignon YJ; Uhrhammer N; Bonadona V; Lasset C; Révillion F; Vennin P; Muller D; Gomes DM; Ingster O; Coupier I; Pujol P; Collonge-Rame MA; Mortemousque I; Bera O; Rose M; Baurand A; Bertolone G; Faivre L; Dreyfus H; Leroux D; Venat-Bouvet L; Bézieau S; Delnatte C; Chiesa J; Gilbert-Dussardier B; Gesta P; Prieur FP, 2020, 'Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes', Nature Genetics, 52, pp. 56 - 73, http://dx.doi.org/10.1038/s41588-019-0537-1

Back to profile page